Using computer models to improve chemical reactions for making useful compounds.
Computational Models for Reactivity and Selectivity in Catalytic Olefin Functionalization
This study is all about finding better ways to create important organic compounds that can help in medicine by using computer models to understand how certain chemical reactions work, which will make it easier for scientists to develop new and improved methods for these reactions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10996102 on NIH RePORTER |
What this research studies
This research focuses on enhancing the synthesis of functionalized organic compounds, which are important for biomedical applications, through advanced computational modeling. By employing techniques like density functional theory and molecular dynamics simulations, the project aims to understand the mechanisms behind catalytic reactions involving alkenes. This understanding will help in predicting how different catalysts can be optimized for better reactivity and selectivity, ultimately guiding experimental efforts in developing new catalytic methods.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals involved in biomedical research or industries focused on drug development and organic synthesis.
Not a fit: Patients not engaged in biomedical research or those not involved in organic compound synthesis may not see direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and targeted methods for synthesizing important biomedical compounds.
How similar studies have performed: Other research has shown success in using computational models to improve catalytic processes, indicating a promising approach in this field.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Liu, Peng — University of Pittsburgh at Pittsburgh
- Study coordinator: Liu, Peng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.